|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
208,280,000 |
Market
Cap: |
1.94(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$5.09 - $15.86 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, in vivo validation capabilities and a cross-functional team to discover medicines. Co.'s potential medicines include: REC-994 for the treatment of cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 for the treatment of familial adenomatous polyposis; REC-3599 for the treatment of GM2 gangliosidosis; REC-3964 for the treatment of C. difficile colitis; REC-64917 for neural or systemic inflammation; and multiple simultaneous programs in fibrosis developing with Bayer AG.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,693,990 |
Total Buy Value |
$0 |
$0 |
$0 |
$12,897,789 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
27 |
Total Shares Sold |
543,020 |
1,104,322 |
2,196,376 |
3,092,957 |
Total Sell Value |
$4,804,664 |
$10,779,617 |
$21,615,561 |
$29,569,657 |
Total People Sold |
4 |
7 |
8 |
8 |
Total Sell Transactions |
21 |
46 |
96 |
151 |
End Date |
2024-03-14 |
2023-12-12 |
2023-06-13 |
2022-06-13 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gibson Christopher |
Chief Executive Officer |
|
2022-10-19 |
4/A |
A |
$0.00 |
$0 |
D/D |
3,000 |
585,805 |
|
- |
|
Virani Shafique |
Chief Business Officer |
|
2022-10-14 |
4 |
AS |
$10.63 |
$109,180 |
D/D |
(10,000) |
88,773 |
|
-22% |
|
Virani Shafique |
Chief Business Officer |
|
2022-10-14 |
4 |
OE |
$2.22 |
$11,100 |
D/D |
5,000 |
98,773 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-10-06 |
4 |
AS |
$11.64 |
$29,105 |
I/I |
(2,500) |
0 |
|
-32% |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
2,500 |
1,000 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-10-06 |
4 |
AS |
$11.50 |
$417,468 |
D/D |
(36,053) |
562,959 |
|
-32% |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
581,459 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-10-06 |
4 |
OE |
$2.48 |
$77,500 |
D/D |
31,250 |
580,512 |
|
- |
|
Chavez R Martin Phd |
Director |
|
2022-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,725 |
33,201 |
|
- |
|
Bogue Zachary |
Director |
|
2022-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
977 |
4,989 |
|
- |
|
Borgeson Blake |
Director |
|
2022-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
920 |
7,672,697 |
|
- |
|
Burrell Terry-Ann |
Director |
|
2022-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,265 |
157,414 |
|
- |
|
Li Dean Y |
Director |
|
2022-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,092 |
620,112 |
|
- |
|
Larson Tina Marriott |
President and COO |
|
2022-09-29 |
4 |
AS |
$10.86 |
$173,749 |
D/D |
(16,000) |
205,107 |
|
-24% |
|
Larson Tina Marriott |
President and COO |
|
2022-09-29 |
4 |
OE |
$1.06 |
$16,960 |
D/D |
16,000 |
221,107 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-09-19 |
4/A |
GD |
$0.00 |
$0 |
D/D |
3,000 |
582,805 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-09-19 |
4/A |
A |
$0.00 |
$0 |
D/D |
3,000 |
585,805 |
|
- |
|
Virani Shafique |
Chief Business Officer |
|
2022-09-15 |
4 |
AS |
$13.34 |
$133,635 |
D/D |
(10,000) |
93,773 |
|
-35% |
|
Virani Shafique |
Chief Business Officer |
|
2022-09-15 |
4 |
OE |
$2.22 |
$11,100 |
D/D |
5,000 |
103,773 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-09-01 |
4 |
AS |
$10.50 |
$26,255 |
I/I |
(2,500) |
0 |
|
-20% |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-09-01 |
4 |
A |
$0.00 |
$0 |
I/I |
2,500 |
1,000 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-09-01 |
4 |
AS |
$10.18 |
$377,944 |
D/D |
(36,566) |
549,262 |
|
-20% |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
567,762 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-09-01 |
4 |
OE |
$2.48 |
$77,500 |
D/D |
31,250 |
567,328 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-08-17 |
4/A |
GD |
$0.00 |
$0 |
D/D |
3,000 |
582,805 |
|
- |
|
618 Records found
|
|
Page 15 of 25 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|